You are currently viewing a new version of our website. To view the old version click .

State-of-the-Art in Eye Cancer

This special issue belongs to the section “Cancer Therapy“.

Special Issue Information

Dear Colleagues,

Ocular oncology is a multidisciplinary field in which advances in imaging, radiotherapy, genetic and molecular understanding are combined to improve clinical outcomes. New imaging technologies, for example, give rise to the development of new strategies for ocular radiotherapy,  reducing post-treatment side effects. Meanwhile, the discovery of new genetic factors, such as the BAP1 tumor predisposition syndrome, has resulted in new clinical screening guidelines. Through these multidisciplinary efforts, our understanding and management of eye cancers, ranging from the eyelids and globe to the complete orbit, have significantly improved in recent years.

In this Special Issue of Cancers, the state of the art in eye cancer will be presented, with  special attention paid to the translation of scientific research between the different disciplines involved in ocular oncology.

Dr. Jan-Willem Beenakker
Dr. Jens Heufelder
Dr. Marina Marinkovic
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ocular oncology
  • uveal melanoma
  • retinoblastoma
  • lymphoma
  • eyelid
  • choroid
  • uvea
  • conjuctiva
  • orbit
  • ocular imaging
  • ocular radiotherapy
  • proton therapy
  • brachytherapy
  • pathology
  • multidisciplinary

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694